Prostate-specific antigen nadir after high-dose-rate brachytherapy predicts long-term survival outcomes in high-risk prostate cancer

Prostate-specific antigen nadir after high-dose-rate brachytherapy predicts long-term survival outcomes in high-risk prostate cancer

Purpose : To evaluate the prognostic value of prostate-specific antigen nadir (nPSA) after high-dose-rate (HDR) brachytherapy in clinically non-metastatic high-risk prostate cancer patients. Material and methods : Data from 216 patients with high-risk or locally advanced prostate cancer who under...

Full description

Bibliographic Details
Main Authors: Hideyasu Tsumura, Takefumi Satoh, Hiromichi Ishiyama, Ken-ichi Tabata, Shouko Komori, Akane Sekiguchi, Masaomi Ikeda, Shinji Kurosaka, Tetsuo Fujita, Masashi Kitano, Kazushige Hayakawa, Masatsugu Iwamura
Format: Article
Language:English
Published: Termedia Publishing House 2016-04-01
Series:Journal of Contemporary Brachytherapy
Subjects:
brachytherapy
high-dose-rate
prostate cancer
PSA nadir
Online Access:https://www.termedia.pl/Prostate-specific-antigen-nadir-after-high-dose-rate-brachytherapy-predicts-long-term-survival-outcomes-in-high-risk-prostate-cancer,54,27482,1,1.html

Internet

https://www.termedia.pl/Prostate-specific-antigen-nadir-after-high-dose-rate-brachytherapy-predicts-long-term-survival-outcomes-in-high-risk-prostate-cancer,54,27482,1,1.html

Similar Items